Skip to main content

Table 1 Characteristics of the systematic reviews included in each overview

From: The impact of different inclusion decisions on the comprehensiveness and complexity of overviews of reviews of healthcare interventions

Overview topic and SR category

Number of included SRs

Years of publication of SRs, median (range)a

AMSTAR score, mean (standard deviation)

Total number of included primary studies

Unique primary studies, n and % included in at least one SRb

Primary study overlap between SRs (“CCA”)c

Overviews for which Cochrane SRs examined all relevant intervention comparisons

 Bronchiolitis

7

2009 (1996–2010)

8.1 (3.0)

55

29

High (14.9)

  Cochrane

4

2010 (2009–2010)

10.5 (0.6)

33

26 (90%)

 

  Non-Cochrane

3

1997 (1996–2004)

5.0 (1.0)

22

13 (45%)

 

 Croup

6

2008 (1989–2010)

8.3 (3.0)

69

53

Moderate (6.0)

  Cochrane

4

2010 (2006–2010)

9.5 (1.9)

51

50 (94%)

 

  Non-Cochrane

2

1995 (1989–2000)

6.0 (4.2)

18

18 (34%)

 

 Gastroenteritis

15

2007 (2001–2012)

7.7 (1.8)

228

114

High (13.3)

  Cochrane

3

2010 (2006–2010)

10.7 (0.6)

88

88 (77%)

 

  Non-Cochrane

12

2007 (2001–2012)

6.9 (1.1)

140

82 (72%)

 

Overviews for which Cochrane SRs did not examine all relevant intervention comparisons

 Acute asthma

13

2011 (1997–2013)

7.8 (2.0)

82

56

Slight (3.9)

  Cochrane

7

2011 (2002–2013)

8.4 (1.8)

48

45 (80%)

 

  Non-Cochrane

6

2006 (1997–2013)

7.0 (2.0)

34

34 (61%)

 

 Acute otitis media

15

2009 (1994–2011)

8.1 (2.6)

260

135

Moderate (6.6)

  Cochrane

6

2009 (2007–2011)

10.2 (0.8)

87

84 (62%)

 

  Non-Cochrane

9

2006 (1994–2010)

6.7 (2.5)

173

107 (79%)

 

 Eczema

19

2007 (2003–2011)

6.6 (2.9)

198

136

Slight (2.5)

  Cochrane

6

2007 (2006–2011)

9.3 (1.8)

29

29 (21%)

 

  Non-Cochrane

13

2008 (2003–2010)

5.4 (2.4)

169

130 (96%)

 

 Procedural sedation

13

2009 (2004–2013)

3.7 (1.8)

180

85

Moderate (9.3)

  Cochrane

0

NA

NA

NA

NA

 

  Non-Cochrane

13

2009 (2004–2013)

3.7 (1.8)

180

85 (100%)

 

All overviews

 Total

88

2008 (1989–2013)

7.0 (2.8)

1072

608

NA

  Cochrane

30

2010 (2002–2013)

9.6 (1.6)

336

322 (53%)

 

  Non-Cochrane

58

2007 (1989–2013)

5.7 (2.3)

736

469 (77%)

 
  1. CCA corrected covered area, NA not applicable, SR systematic review
  2. aFor Cochrane SRs we used the year last assessed as up-to-date
  3. bEach primary study was counted only once, regardless of how many SRs included that study
  4. cCategorized using published criteria as “slight” (0–5), “moderate” (6–10), “high” (11–15), or “very high” (> 15)